Mallinckrodt Expands Portfolio
H.P. Acthar® Gel (repository corticotropin injection) is now part of Mallinckrodt’s new Autoimmune and Rare Diseases business.
Commitment to the Community
From our headquarters to operating sites around the world, Mallinckrodt's philanthropic activities strive to advance society in meaningful ways.
We are a global company, developing, manufacturing and distributing specialty pharmaceutical products and diagnostic imaging agents.
The Mallinckrodt Story
Building our future on a heritage of more than 145 years